Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-16,700
Closed -$11.1K 10737
2024
Q4
$11.1K Sell
16,700
-1,100
-6% -$764 ﹤0.01% 9174
2024
Q3
$15.1K Sell
17,800
-800
-4% -$612 ﹤0.01% 9322
2024
Q2
$12.4K Buy
+18,600
New +$15.4K ﹤0.01% 9084
2023
Q1
Sell
-74,400
Closed -$71.5K 10023
2022
Q4
$71.5K Sell
74,400
-44,700
-38% -$63.2K ﹤0.01% 8249
2022
Q3
$260K Buy
119,100
+27,800
+30% +$95.9K ﹤0.01% 7803
2022
Q2
$320K Sell
91,300
-52,400
-36% -$196K ﹤0.01% 7508
2022
Q1
$724K Sell
143,700
-280,700
-66% -$1.42M ﹤0.01% 6786
2021
Q4
$2.66M Buy
424,400
+25,100
+6% +$171K ﹤0.01% 3920
2021
Q3
$3.17M Sell
399,300
-236,500
-37% -$1.95M ﹤0.01% 3553
2021
Q2
$4.76M Buy
635,800
+390,200
+159% +$2.72M ﹤0.01% 2720
2021
Q1
$1.49M Sell
245,600
-36,700
-13% -$282K ﹤0.01% 4627
2020
Q4
$1.61M Sell
282,300
-214,900
-43% -$1.37M ﹤0.01% 3897
2020
Q3
$3.31M Buy
+497,200
New +$4.43M ﹤0.01% 2319

Other funds holding VXRT

Jane Street's VXRT Position: Q2 2025 in Review

Jane Street sold out of Vaxart (VXRT) in Q2 2025, closing a stake of 30,516 shares — an estimated $12.4K sold.

Jane Street first reported a position in VXRT in Q1 2014 and held it in 20 quarters. The position peaked at $1.91M in Q4 2020. 98 funds tracked by Wall St. Rank hold VXRT as of Q2 2025.

  • Jane Street reported no remaining Vaxart position as of Q2 2025 after selling out during the quarter.
  • Jane Street sold 30,516 Vaxart shares in Q2 2025, an estimated $12.4K.
  • Jane Street first reported a position in Vaxart in Q1 2014 and held it in 20 quarters.
  • Jane Street's Vaxart position peaked at $1.91M in Q4 2020.
  • 98 funds tracked by Wall St. Rank held Vaxart as of Q2 2025.

Based on Jane Street's 13F filing for Q2 2025, filed 14 Aug 2025.